Skip to content

Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on COPD (Chronic Obstructive Pulmonary Disease) Patients

Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on Pulmonary Parameters Functional Capacity and Balance Among COPD (Chronic Obstructive Pulmonary Disease) Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07106086
Enrollment
40
Registered
2025-08-06
Start date
2024-07-20
Completion date
2024-12-30
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Balance, Breathing, COPD, Functional Capacity, Mobilization

Brief summary

The objective of this study will be to determine the combine effect of scapulothoracic mobilization with Buteyko breathing on pulmonary parameters functional capacity and balance among COPD patient.

Detailed description

The study will be Randomized Clinical Trial which include forty (40) subjects clinically diagnosed according to Global Initiative for Obstructive Lung Disease (GOLD) standard of chronic obstructive pulmonary disease (COPD). Patients will be allocated into two groups i.e. Group A (20) and Group B (20). Group A scapulothoracic mobilization with Buteyko breathing (BBT) and Group B received Buteyko breathing (BBT). The Pulse oximeter will be used to evaluate Pulmonary parameters. The 6-meter walk test will be used to assess functional capacity. The Activities-specific balance confidence scale (ABC scale) will be used to assess Balance Confidence and Single leg stance (SLS) will be used to evaluate balance. The evaluation will be done on day one as pretreatment values and post-treatment values at the end of third week.

Interventions

Scapulothoracic Mobilization and Buteyko Breathing Technique: Subjects lay supine with arms crossed, hands on opposite scapulae. The interventionist stabilized elbows and applied pressure to shoulders, with one hand on the spine using a loose fist to mobilize vertebrae. Various spinal motions-rotation, flexion, lateral flexion, and translation-were assessed. In a lateral position, the subject bent both knees and placed the upper arm on a cushion. The interventionist stood close, placing fingers under the scapula's medial border.

Buteyko Breathing: Subjects sat upright, relaxed respiratory muscles, and breathed gently through the nose. The sequence included calm nasal inhalation and exhalation using the diaphragm, followed by shallow inhalation and slow exhalation. A brief post-exhalation breath hold was added. The cycle was repeated for several minutes.

Sponsors

Rashid Latif Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinically Diagnosed COPD is confirmed by diagnostic criteria of COPD (forced expiratory volume in 1 second \[FEV1\] \<80% predicted, FEV1/forced vital capacity \[FVC\] \<0.7 predicted) according to the international guideline and the ability to provide inform consent. * Patients with Resting Respiratory Rate \>\_ 24

Exclusion criteria

* Patients diagnosed with a primary pulmonary vascular disease * Patients diagnosed with severe psychiatric disorders and cognitive dysfunction * Patients diagnosed severe auditory/visual impairments * Patients diagnosed Musculoskeletal, Rheumatic ,Cardiac/Neurological disorder and Malignancies * Patients diagnosed with skin, peripheral vascular disorder excluded

Design outcomes

Primary

MeasureTime frameDescription
Oxygen SaturationPre and 2 week Post interventionOxygen saturation is measured by Pulse oximeter The gold standard for measuring arterial blood oxygen saturation (SaO₂) requires arterial blood sampling, but pulse oximetry provides a non-invasive estimate (SpO₂) widely used to detect hypoxemia.
Functional capacityPre and 2 week post interventionFunctional Capacity is measured by 6- minute walk test. The 6-minute walk test (6MWT) is a well-known tool to measure ability to walk and endurance in the sub-maximal condition. The 6MWT is a exercise test that involves measuring the distance walked over a span of 6 minutes. Participants were encouraged to walk on a straight, flat surface as fast as possible for 6 minutes on a marked course, with pauses as necessary.
BalancePre and 2 week post interventionThe Balance is measured by Single leg stance test. Single Leg Stance (SLS). The SLS is a simple balance test where the participant stands on one leg for as long as possible (up to 60 seconds) with hands on hips. The test is performed first with eyes open, then with eyes closed. Longer duration indicates better balance. The SLS has demonstrated excellent reliability in individuals with COPD as well as in community-dwelling older adults.

Secondary

MeasureTime frameDescription
Respiratory ratePre and Post 2 week interventionRespiratory rate is measured by Pulse oximeter Pulse oximetry can reliably estimate respiratory rate (RR) and is suitable for wearable use due to its compactness and cost-effectiveness.
Heart ratePre and Post 2 week interventionHeart rate is measured by the Pulse oximeter. Normal resting heart rate ranges from 60-100 bpm, but it may fluctuate. COPD patients often show elevated resting HR. Pulse oximeters can effectively monitor HR.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026